A Gain-of-Function Mutation in the Ca2+ Channel ORAI1 Causes Stormorken Syndrome with Tubular Aggregates in Mice
Cells · 2024
DOI: 10.3390/cells13221829 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2024. Verfasst von Laura Pérez-Guàrdia und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Inserm U1258, CNRS UMR7104, Université de Strasbourg, 67404 Illkirch, France. Hauptthemen laut MEDLINE: ORAI1 Protein, Gain of Function Mutation, Blood Platelet Disorders, Stromal Interaction Molecule 1. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: AFM-Téléthon, IdEx Unistra, SFRI-STRAT’US project.
Abstract (Originalsprache)
Store-operated Ca2+ entry (SOCE) controls Ca2+ homeostasis and mediates multiple Ca2+-dependent signaling pathways and cellular processes. It relies on the concerted activity of the reticular Ca2+ sensor STIM1 and the plasma membrane Ca2+ channel ORAI1. STIM1 and ORAI1 gain-of-function (GoF) mutations induce SOCE overactivity and excessive Ca2+ influx, leading to tubular aggregate myopathy (TAM) and Stormorken syndrome (STRMK), two overlapping disorders characterized by muscle weakness and a variable occurrence of multi-systemic anomalies affecting spleen, skin, and platelets. To date, different STIM1 mouse models exist, but only a single ORAI1 mouse model with muscle-specific TAM/STRMK phenotype has been described, precluding a comparative analysis of the physiopathology in all affected tissues. Here, we generated and characterized mice harboring a prevalent ORAI1 TAM/STRMK mutation and we provide phenotypic, physiological, biochemical, and functional data. Examination of Orai1V109M/+ mice revealed smaller size, spleen enlargement, reduced muscle force, and decreased platelet numbers. Morphological analyses of muscle sections evidenced the presence of tubular aggregates, the histopathological hallmark on biopsies from TAM/STRMK patients absent in all reported STIM1 models. Overall, Orai1V109M/+ mice reliably recapitulate the human disorder and highlight the primary physiological defects caused by ORAI1 gain-of-function mutations. They also provide the possibility to investigate the formation of tubular aggregates and to develop a common therapy for different TAM/STRMK forms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Inserm U1258, CNRS UMR7104, Université de Strasbourg, 67404 Illkirch, France.
ORCID-Profile: Laura Pérez-Guàrdia, Coralie Spiegelhalter, Jocelyn Laporte, Johann Böhm
Förderung
- AFM-Téléthon
- IdEx Unistra
- SFRI-STRAT’US project
- EUR IMCBio
- Agence Nationale de la Recherche
- ODYSSY
- Investissements d’Avenir
- Association Française contre les Myopathies
Zitieren
APA
Pérez-Guàrdia, L., Lafabrie, E., Diedhiou, N., Spiegelhalter, C., Laporte, J., & Böhm, J. (2024). A Gain-of-Function Mutation in the Ca2+ Channel ORAI1 Causes Stormorken Syndrome with Tubular Aggregates in Mice. Cells. https://doi.org/10.3390/cells13221829
Vancouver
Pérez-Guàrdia L, Lafabrie E, Diedhiou N, Spiegelhalter C, Laporte J, Böhm J. A Gain-of-Function Mutation in the Ca2+ Channel ORAI1 Causes Stormorken Syndrome with Tubular Aggregates in Mice. Cells. 2024. doi:10.3390/cells13221829
BibTeX
@article{PrezGurdia2024,
author = {Pérez-Guàrdia, Laura and Lafabrie, Emma and Diedhiou, Nadège and Spiegelhalter, Coralie and Laporte, Jocelyn and Böhm, Johann},
title = {A Gain-of-Function Mutation in the Ca2+ Channel ORAI1 Causes Stormorken Syndrome with Tubular Aggregates in Mice},
journal = {Cells},
year = {2024},
doi = {10.3390/cells13221829}
}
EUVIMED